Laurus Labs May Rally 35% Says Motilal Oswal - Key Triggers And Target Price Inside
Published on: March 20, 2026, 11:16 a.m. | Source: NDTV Profit
Laurus is witnessing a strong scale-up in CDMO business from global innovator pharma, including rare formulation-level contracts for patented products, adds Motilal Oswal.
